Even when prostate cancer has spread to other regions of the body, it is usually treatable for an extended period. As a result, even men with advanced prostate cancer can enjoy good health for many years. However, if not properly treated, prostate cancer can cause serious symptoms and even ...
These general survival rates are based on those who receive an initial lung cancer diagnosis at stage 4. This doesn’t apply to lung cancer that has returned. While no one can know the exact answers about your life expectancy, we do know stage 4 lung cancer patients are living longer now ...
PATIENTS AND METHODS Patients Patients X18 years of age were required to have histologically confirmed stage IV melanoma according to the American Joint Committee on Cancer criteria (Balch et al, 2001, 2002), radio- graphically measurable disease (as defined by Response Evaluation Criteria in Solid ...
Small-cell lung cancer (SCLC) represents approximately 15% of lung cancer cases and has a poor prognosis; about two-thirds of patients present at an extensive-stage (ES) disease state, and the 5-year overall survival (OS) rate is limited to only 1–5% (refs.1,2). The addition of an...
Limited-stage (LS) small-cell lung cancer (SCLC) remains an area of high unmet medical need. The standard-of-care therapy comprises curative-intent platinum-based chemotherapy with concurrent radiotherapy (cCRT), which can be followed by prophylactic brain irradiation and then observation. However,...
Designing and evaluating the effectiveness of an integrative health care model for women at the climacteric stage, based on the empowerment approach and focus on health-related self-care to improve their HR-QoL is pertinent for current health conditions of this age group. Trial registration The ...
the Netherlands Response rate and toxicity of second-line therapy with docetaxel (75 mg mÀ2) or docetaxel, irinotecan, and lenogastrim (60 mg mÀ2, 200 mg mÀ2, and 150 mg mÀ2 dayÀ1, respectively) were compared in 108 patients with stage IIIb – IV non-small-cell lung cancer....
This was an investigator initiated trial which was sponsored by the University of Cologne and the FCGCLL. The trial was primarily funded by the German Cancer Aid (106142/107080) and the French National Research Agency (ANR). Additional funding support, as well as the study drug rituximab was ...
Advanced Research in Oncology in 2023Advanced Research in Oncology in 2024Advanced Research in Oncology in 2025Advanced Therapies for Hematological CancersAdvances and Research Progress in Hepatocellular CarcinomaAdvances in Bone Metastatic Cancer ResearchAdvances in Breast Cancer: A Themed Issue in Honor of...
Background: Since haemodialysis is a lifesaving therapy, adequate control measures are necessary to evaluate its adequacy and to constantly adjust the dose to reduce hospitalisation and prolong patient survival. Malnutrition is common in haemodialysis patients and closely related to morbidity and mortality...